Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118458) titled 'A phase III study of tetramethylpyrazine nitrone (TBN) combined treatment with alteplase (rt-PA) in acute ischemic stroke"' on Feb. 5.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
acute ischemic stroke
Intervention:
Intervention group:TBN for Injection, i.v.drip
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2026-02-06
Target Sample Size: Intervention group:660;Placebo group:660;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=229178
...